Palermo G, Joris H, Devroey P, Van Steirteghem A C
Centre for Reproductive Medicine, Vrije Universiteit Brussel, Belgium.
Lancet. 1992 Jul 4;340(8810):17-8. doi: 10.1016/0140-6736(92)92425-f.
Intracytoplasmic sperm injection (ICSI) is a promising assisted-fertilisation technique that may benefit women who have not become pregnant by in-vitro fertilisation (IVF) or subzonal insemination (SUZI) of oocytes. We have used ICSI to treat couples with infertility because of severely impaired sperm characteristics, and in whom IVF and SUZI had failed. Direct injection of a single spermatozoon into the ooplasm was done in 47 metaphase-II oocytes: 38 oocytes remained intact after injection, 31 became fertilised, and 15 embryos were replaced in utero. Four pregnancies occurred after eight treatment cycles--two singleton and one twin pregnancy, and a preclinical abortion. Two healthy boys have been delivered from the singleton pregnancies and a healthy boy and girl from the twin pregnancy.
卵胞浆内单精子注射(ICSI)是一种很有前景的辅助受精技术,可能会使那些通过体外受精(IVF)或卵母细胞透明带下授精(SUZI)仍未怀孕的女性受益。我们已使用ICSI来治疗因精子特征严重受损而不育的夫妇,这些夫妇的IVF和SUZI均告失败。将单个精子直接注射到47个处于中期II的卵母细胞的卵质中:注射后38个卵母细胞保持完整,31个受精,15个胚胎被植入子宫。经过八个治疗周期后出现了四次妊娠——两次单胎妊娠和一次双胎妊娠,还有一次临床前流产。单胎妊娠已分娩出两个健康男婴,双胎妊娠已分娩出一个健康男婴和一个健康女婴。